 Kimberley Bruce
Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 6 | 2025 | 269 | 3.040 |
Why?
| | Alzheimer Disease | 4 | 2025 | 622 | 1.780 |
Why?
| | Lipoproteins | 4 | 2025 | 165 | 1.640 |
Why?
| | Lipid Metabolism | 4 | 2025 | 524 | 1.490 |
Why?
| | Muromegalovirus | 9 | 2022 | 23 | 1.270 |
Why?
| | Brain | 6 | 2025 | 2934 | 1.160 |
Why?
| | Fatty Liver | 4 | 2018 | 250 | 1.050 |
Why?
| | Lipoprotein Lipase | 4 | 2022 | 56 | 0.940 |
Why?
| | Herpesviridae Infections | 8 | 2024 | 149 | 0.920 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2019 | 265 | 0.910 |
Why?
| | Membrane Glycoproteins | 5 | 2026 | 496 | 0.850 |
Why?
| | Fructose | 1 | 2025 | 131 | 0.830 |
Why?
| | Prenatal Exposure Delayed Effects | 6 | 2019 | 641 | 0.820 |
Why?
| | Receptors, Immunologic | 4 | 2026 | 206 | 0.810 |
Why?
| | Metabolic Syndrome | 3 | 2011 | 354 | 0.720 |
Why?
| | Fatty Acids | 2 | 2022 | 454 | 0.720 |
Why?
| | Neuroglia | 1 | 2022 | 173 | 0.680 |
Why?
| | Optical Imaging | 1 | 2021 | 61 | 0.670 |
Why?
| | Lipid Droplets | 1 | 2021 | 19 | 0.660 |
Why?
| | Glucose Intolerance | 1 | 2022 | 142 | 0.660 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 438 | 0.640 |
Why?
| | Dietary Fats | 4 | 2026 | 308 | 0.630 |
Why?
| | Neurodegenerative Diseases | 2 | 2021 | 150 | 0.630 |
Why?
| | DNA Methylation | 2 | 2023 | 664 | 0.620 |
Why?
| | Circadian Clocks | 4 | 2019 | 59 | 0.590 |
Why?
| | Animals | 39 | 2026 | 37948 | 0.580 |
Why?
| | Diet, High-Fat | 8 | 2019 | 261 | 0.560 |
Why?
| | Neurons | 3 | 2022 | 1639 | 0.540 |
Why?
| | Genes, Essential | 4 | 2014 | 21 | 0.500 |
Why?
| | Mice | 29 | 2026 | 18261 | 0.480 |
Why?
| | CLOCK Proteins | 1 | 2016 | 9 | 0.480 |
Why?
| | Sirtuin 1 | 1 | 2016 | 34 | 0.470 |
Why?
| | Disease Susceptibility | 1 | 2018 | 342 | 0.470 |
Why?
| | Disease Models, Animal | 8 | 2024 | 4539 | 0.460 |
Why?
| | Maternal Nutritional Physiological Phenomena | 4 | 2014 | 178 | 0.460 |
Why?
| | Sirtuin 3 | 1 | 2016 | 58 | 0.450 |
Why?
| | Nutritional Physiological Phenomena | 2 | 2012 | 56 | 0.440 |
Why?
| | Cytomegalovirus Infections | 3 | 2022 | 205 | 0.430 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 771 | 0.410 |
Why?
| | Dendritic Cells | 4 | 2021 | 498 | 0.380 |
Why?
| | Mice, Inbred C57BL | 13 | 2026 | 5967 | 0.380 |
Why?
| | 14-3-3 Proteins | 1 | 2012 | 15 | 0.370 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2026 | 231 | 0.350 |
Why?
| | Phospholipids | 2 | 2025 | 214 | 0.350 |
Why?
| | Viral Proteins | 3 | 2024 | 353 | 0.330 |
Why?
| | Liver | 4 | 2016 | 1889 | 0.320 |
Why?
| | Lipogenesis | 2 | 2009 | 62 | 0.310 |
Why?
| | Molecular Dynamics Simulation | 3 | 2026 | 262 | 0.300 |
Why?
| | Mitochondria, Liver | 1 | 2009 | 70 | 0.300 |
Why?
| | Epigenesis, Genetic | 2 | 2011 | 669 | 0.290 |
Why?
| | Virus Replication | 3 | 2021 | 525 | 0.280 |
Why?
| | Salivary Glands | 4 | 2021 | 36 | 0.280 |
Why?
| | Olfactory Mucosa | 3 | 2024 | 39 | 0.270 |
Why?
| | Suprachiasmatic Nucleus | 2 | 2019 | 19 | 0.260 |
Why?
| | Killer Cells, Natural | 2 | 2024 | 470 | 0.260 |
Why?
| | Obesity | 5 | 2026 | 3070 | 0.260 |
Why?
| | Lymph Nodes | 4 | 2021 | 501 | 0.250 |
Why?
| | Gene Expression Regulation | 5 | 2021 | 2591 | 0.250 |
Why?
| | Rhadinovirus | 2 | 2024 | 20 | 0.250 |
Why?
| | Humans | 28 | 2026 | 144667 | 0.250 |
Why?
| | Virus Internalization | 3 | 2021 | 65 | 0.250 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2024 | 1129 | 0.240 |
Why?
| | Pregnancy | 9 | 2019 | 7122 | 0.240 |
Why?
| | Receptors, Lipoprotein | 1 | 2026 | 15 | 0.240 |
Why?
| | Energy Metabolism | 1 | 2012 | 927 | 0.240 |
Why?
| | Triglycerides | 3 | 2023 | 517 | 0.240 |
Why?
| | Intestinal Absorption | 1 | 2026 | 103 | 0.230 |
Why?
| | Mice, Inbred BALB C | 7 | 2021 | 1251 | 0.220 |
Why?
| | Apolipoprotein E4 | 1 | 2025 | 41 | 0.220 |
Why?
| | Trigeminal Ganglion | 1 | 2024 | 26 | 0.210 |
Why?
| | Central Nervous System | 2 | 2024 | 279 | 0.210 |
Why?
| | Receptors, Interferon | 1 | 2024 | 60 | 0.200 |
Why?
| | Herpes Simplex | 1 | 2024 | 98 | 0.200 |
Why?
| | Herpesvirus 1, Human | 1 | 2024 | 84 | 0.200 |
Why?
| | Interferon-gamma | 2 | 2024 | 781 | 0.200 |
Why?
| | Phenotype | 4 | 2021 | 3147 | 0.200 |
Why?
| | Lipodystrophy | 1 | 2022 | 13 | 0.190 |
Why?
| | Hypertriglyceridemia | 1 | 2022 | 44 | 0.180 |
Why?
| | Gene Expression Profiling | 4 | 2021 | 1766 | 0.180 |
Why?
| | Diet | 3 | 2023 | 1270 | 0.180 |
Why?
| | Circadian Rhythm | 3 | 2016 | 510 | 0.180 |
Why?
| | Superinfection | 1 | 2021 | 6 | 0.170 |
Why?
| | Cytomegalovirus Vaccines | 1 | 2021 | 5 | 0.170 |
Why?
| | Nanoparticles | 2 | 2020 | 512 | 0.170 |
Why?
| | Acinar Cells | 1 | 2021 | 13 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 171 | 0.170 |
Why?
| | Herpesviridae | 1 | 2021 | 22 | 0.170 |
Why?
| | Tissue Adhesions | 2 | 2012 | 34 | 0.170 |
Why?
| | Chemokines, CC | 1 | 2021 | 32 | 0.170 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2021 | 17 | 0.170 |
Why?
| | Estrogens | 1 | 2024 | 364 | 0.170 |
Why?
| | Substrate Specificity | 1 | 2021 | 392 | 0.160 |
Why?
| | Herpesvirus 3, Human | 1 | 2024 | 337 | 0.160 |
Why?
| | Ultracentrifugation | 1 | 2020 | 50 | 0.160 |
Why?
| | Cytomegalovirus | 1 | 2021 | 168 | 0.160 |
Why?
| | Recombination, Genetic | 1 | 2021 | 205 | 0.160 |
Why?
| | Cholesterol, LDL | 1 | 2022 | 359 | 0.160 |
Why?
| | Inflammation | 4 | 2021 | 2870 | 0.150 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 854 | 0.150 |
Why?
| | Cell Death | 1 | 2021 | 382 | 0.150 |
Why?
| | Positron-Emission Tomography | 1 | 2021 | 343 | 0.150 |
Why?
| | Tobramycin | 1 | 2019 | 59 | 0.150 |
Why?
| | Astrocytes | 1 | 2021 | 228 | 0.150 |
Why?
| | Exosomes | 1 | 2020 | 104 | 0.150 |
Why?
| | Female | 17 | 2024 | 78304 | 0.150 |
Why?
| | Hypothalamus | 2 | 2017 | 160 | 0.150 |
Why?
| | Insulin Resistance | 2 | 2022 | 1241 | 0.140 |
Why?
| | Lipids | 2 | 2021 | 706 | 0.140 |
Why?
| | Photoperiod | 2 | 2016 | 55 | 0.140 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2021 | 625 | 0.140 |
Why?
| | Cholesterol | 1 | 2021 | 404 | 0.140 |
Why?
| | Quinolines | 1 | 2019 | 192 | 0.140 |
Why?
| | Myeloid Cells | 1 | 2019 | 146 | 0.140 |
Why?
| | Viral Envelope Proteins | 1 | 2019 | 98 | 0.140 |
Why?
| | Precision Medicine | 1 | 2022 | 454 | 0.130 |
Why?
| | Cell Line | 2 | 2021 | 2821 | 0.130 |
Why?
| | Pravastatin | 1 | 2017 | 44 | 0.120 |
Why?
| | Simvastatin | 1 | 2017 | 59 | 0.120 |
Why?
| | Pseudomonas aeruginosa | 1 | 2019 | 391 | 0.120 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2016 | 3 | 0.120 |
Why?
| | Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2016 | 3 | 0.120 |
Why?
| | Muscular Diseases | 1 | 2017 | 108 | 0.120 |
Why?
| | Fibrosis | 1 | 2019 | 547 | 0.120 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2016 | 56 | 0.120 |
Why?
| | Glucose | 2 | 2022 | 1033 | 0.120 |
Why?
| | Lung | 5 | 2024 | 4089 | 0.120 |
Why?
| | Hyperlipidemias | 1 | 2017 | 120 | 0.120 |
Why?
| | Maternal Exposure | 1 | 2018 | 185 | 0.120 |
Why?
| | Acidosis | 1 | 2017 | 105 | 0.120 |
Why?
| | Interferon Type I | 1 | 2016 | 146 | 0.110 |
Why?
| | Macrophages | 3 | 2024 | 1496 | 0.110 |
Why?
| | Body Composition | 2 | 2017 | 689 | 0.110 |
Why?
| | Serum Albumin, Bovine | 1 | 2015 | 59 | 0.110 |
Why?
| | Immunity, Innate | 2 | 2021 | 843 | 0.110 |
Why?
| | Oxidation-Reduction | 2 | 2016 | 1078 | 0.110 |
Why?
| | Eating | 2 | 2019 | 388 | 0.110 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2014 | 11 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 204 | 0.110 |
Why?
| | Lipoproteins, HDL | 2 | 2026 | 99 | 0.100 |
Why?
| | Biopsy | 1 | 2018 | 1079 | 0.100 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 23 | 0.100 |
Why?
| | Adiposity | 2 | 2016 | 529 | 0.100 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1705 | 0.100 |
Why?
| | Proteomics | 1 | 2020 | 1183 | 0.100 |
Why?
| | Fibroblasts | 1 | 2019 | 1019 | 0.100 |
Why?
| | Weight Gain | 1 | 2017 | 557 | 0.100 |
Why?
| | Aging | 1 | 2024 | 1938 | 0.090 |
Why?
| | Repressor Proteins | 1 | 2016 | 428 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2019 | 1106 | 0.090 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 2 | 2009 | 55 | 0.090 |
Why?
| | Ovary | 1 | 2014 | 226 | 0.090 |
Why?
| | Binding Sites | 2 | 2026 | 1307 | 0.090 |
Why?
| | Virus Activation | 2 | 2024 | 95 | 0.090 |
Why?
| | Mice, Knockout | 4 | 2026 | 3109 | 0.090 |
Why?
| | Actins | 1 | 2014 | 421 | 0.090 |
Why?
| | Appetite | 1 | 2012 | 71 | 0.090 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 380 | 0.090 |
Why?
| | Endometrium | 1 | 2011 | 59 | 0.090 |
Why?
| | Liver Transplantation | 1 | 2019 | 826 | 0.090 |
Why?
| | Blood Vessels | 1 | 2012 | 167 | 0.080 |
Why?
| | Epithelium | 1 | 2012 | 310 | 0.080 |
Why?
| | Nose | 2 | 2021 | 68 | 0.080 |
Why?
| | Disease Progression | 1 | 2019 | 2847 | 0.080 |
Why?
| | MicroRNAs | 2 | 2024 | 689 | 0.080 |
Why?
| | Male | 11 | 2026 | 72431 | 0.080 |
Why?
| | Models, Biological | 3 | 2017 | 1811 | 0.080 |
Why?
| | Pelvic Pain | 1 | 2010 | 42 | 0.080 |
Why?
| | Electron Transport | 1 | 2009 | 115 | 0.070 |
Why?
| | Adipokines | 1 | 2009 | 57 | 0.070 |
Why?
| | Hyaluronan Receptors | 1 | 2009 | 104 | 0.070 |
Why?
| | Protein Binding | 2 | 2025 | 2243 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3888 | 0.070 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2011 | 180 | 0.070 |
Why?
| | Intra-Abdominal Fat | 1 | 2009 | 100 | 0.070 |
Why?
| | Viremia | 2 | 2021 | 159 | 0.070 |
Why?
| | Lactation | 1 | 2009 | 192 | 0.070 |
Why?
| | Genetic Variation | 1 | 2012 | 985 | 0.060 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 906 | 0.060 |
Why?
| | Signal Transduction | 2 | 2021 | 5185 | 0.060 |
Why?
| | Body Weight | 3 | 2017 | 968 | 0.060 |
Why?
| | Feeding Behavior | 1 | 2012 | 686 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1047 | 0.060 |
Why?
| | Chylomicrons | 1 | 2026 | 18 | 0.060 |
Why?
| | Oxidative Stress | 2 | 2009 | 1338 | 0.060 |
Why?
| | Histones | 1 | 2011 | 663 | 0.060 |
Why?
| | Intestine, Small | 1 | 2026 | 167 | 0.050 |
Why?
| | Varicella Zoster Virus Infection | 1 | 2024 | 27 | 0.050 |
Why?
| | Ligands | 1 | 2026 | 662 | 0.050 |
Why?
| | CD11c Antigen | 1 | 2024 | 40 | 0.050 |
Why?
| | Virus Latency | 1 | 2024 | 90 | 0.050 |
Why?
| | Gene Expression | 3 | 2014 | 1476 | 0.050 |
Why?
| | Protein Domains | 1 | 2025 | 313 | 0.050 |
Why?
| | Aged | 1 | 2024 | 25955 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 98 | 0.050 |
Why?
| | Sleep | 1 | 2010 | 890 | 0.050 |
Why?
| | Coloring Agents | 1 | 2023 | 91 | 0.050 |
Why?
| | Alveolar Epithelial Cells | 1 | 2024 | 120 | 0.050 |
Why?
| | Apolipoprotein C-III | 1 | 2022 | 11 | 0.050 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2024 | 365 | 0.050 |
Why?
| | Oligonucleotides, Antisense | 1 | 2022 | 117 | 0.040 |
Why?
| | Phospholipase C beta | 1 | 2021 | 30 | 0.040 |
Why?
| | Protein Conformation | 1 | 2025 | 935 | 0.040 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2021 | 20 | 0.040 |
Why?
| | Neurotoxins | 1 | 2021 | 28 | 0.040 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2021 | 27 | 0.040 |
Why?
| | Oligonucleotides | 1 | 2022 | 151 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 111 | 0.040 |
Why?
| | Middle Aged | 1 | 2024 | 35971 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2021 | 88 | 0.040 |
Why?
| | Receptors, Odorant | 1 | 2021 | 32 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2021 | 117 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2350 | 0.040 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 145 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2021 | 131 | 0.040 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 129 | 0.040 |
Why?
| | Virion | 1 | 2021 | 111 | 0.040 |
Why?
| | Abdomen | 2 | 2012 | 141 | 0.040 |
Why?
| | Chemical Precipitation | 1 | 2020 | 39 | 0.040 |
Why?
| | Herpes Zoster | 1 | 2024 | 315 | 0.040 |
Why?
| | Mutation | 2 | 2021 | 4081 | 0.040 |
Why?
| | Benzofurans | 1 | 2019 | 26 | 0.040 |
Why?
| | Animal Structures | 1 | 2019 | 11 | 0.040 |
Why?
| | Microbial Viability | 1 | 2019 | 91 | 0.040 |
Why?
| | Body Fluids | 1 | 2019 | 71 | 0.040 |
Why?
| | Nitric Oxide | 2 | 2015 | 894 | 0.040 |
Why?
| | Drug Synergism | 1 | 2019 | 352 | 0.040 |
Why?
| | Interleukin-6 | 2 | 2015 | 770 | 0.040 |
Why?
| | Disease Transmission, Infectious | 1 | 2019 | 68 | 0.040 |
Why?
| | Environmental Monitoring | 1 | 2021 | 374 | 0.040 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 368 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2019 | 373 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2015 | 1207 | 0.030 |
Why?
| | Biodiversity | 1 | 2021 | 425 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 915 | 0.030 |
Why?
| | Receptors, Chemokine | 1 | 2017 | 47 | 0.030 |
Why?
| | Chylomicron Remnants | 1 | 2017 | 1 | 0.030 |
Why?
| | Calorimetry | 1 | 2017 | 69 | 0.030 |
Why?
| | Hydrolysis | 1 | 2017 | 198 | 0.030 |
Why?
| | Risk Factors | 1 | 2011 | 10796 | 0.030 |
Why?
| | Dependovirus | 1 | 2017 | 77 | 0.030 |
Why?
| | Ecosystem | 1 | 2021 | 591 | 0.030 |
Why?
| | Ceramides | 1 | 2017 | 117 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 765 | 0.030 |
Why?
| | Calorimetry, Indirect | 1 | 2016 | 72 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2017 | 360 | 0.030 |
Why?
| | Gene Deletion | 1 | 2017 | 392 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2017 | 407 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2019 | 0.030 |
Why?
| | Leukocyte Reduction Procedures | 1 | 2015 | 29 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1447 | 0.030 |
Why?
| | Cell Count | 1 | 2015 | 320 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2015 | 335 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 369 | 0.030 |
Why?
| | Algorithms | 2 | 2012 | 1844 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 570 | 0.020 |
Why?
| | Time Factors | 2 | 2017 | 7140 | 0.020 |
Why?
| | Organ Size | 1 | 2014 | 461 | 0.020 |
Why?
| | Homeostasis | 1 | 2017 | 639 | 0.020 |
Why?
| | Adult | 4 | 2022 | 40489 | 0.020 |
Why?
| | Spleen | 1 | 2015 | 510 | 0.020 |
Why?
| | Vaccination | 1 | 2021 | 1419 | 0.020 |
Why?
| | Weaning | 1 | 2012 | 51 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2015 | 630 | 0.020 |
Why?
| | Systole | 1 | 2012 | 177 | 0.020 |
Why?
| | Peritoneum | 1 | 2012 | 44 | 0.020 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2012 | 66 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2011 | 16 | 0.020 |
Why?
| | Reference Standards | 1 | 2012 | 178 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2012 | 203 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2017 | 2184 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2014 | 890 | 0.020 |
Why?
| | Vasoconstriction | 1 | 2012 | 216 | 0.020 |
Why?
| | Femoral Artery | 1 | 2012 | 190 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4110 | 0.020 |
Why?
| | Peritoneal Diseases | 1 | 2010 | 4 | 0.020 |
Why?
| | Femur | 1 | 2012 | 251 | 0.020 |
Why?
| | Menstrual Cycle | 1 | 2011 | 140 | 0.020 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2010 | 85 | 0.020 |
Why?
| | Intestinal Obstruction | 1 | 2010 | 55 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1301 | 0.020 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2009 | 24 | 0.020 |
Why?
| | PPAR alpha | 1 | 2009 | 54 | 0.020 |
Why?
| | Preoperative Care | 1 | 2012 | 379 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2009 | 116 | 0.020 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2009 | 49 | 0.020 |
Why?
| | Vasodilation | 1 | 2012 | 520 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 675 | 0.020 |
Why?
| | Laparoscopy | 1 | 2012 | 477 | 0.020 |
Why?
| | Kidney | 1 | 2015 | 1495 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 848 | 0.020 |
Why?
| | Software | 1 | 2011 | 695 | 0.010 |
Why?
| | Blood Pressure | 1 | 2012 | 1766 | 0.010 |
Why?
| | RNA | 1 | 2011 | 926 | 0.010 |
Why?
| | Chronic Disease | 1 | 2010 | 1810 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2011 | 3603 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2815 | 0.010 |
Why?
| | Biomarkers | 1 | 2009 | 4261 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2009 | 2172 | 0.010 |
Why?
|
|
Bruce's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|